Notably, genes downregulated by ARHGEF2 deletion were associated with critical pathways, namely, pathways in cancer, MAPK signaling pathway, central carbon metabolism in cancer and prostate cancer pathway. Here, ARHGEF2 is linked to prostate carcinoma.